- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 654976 [Title] => Roche posts solid results in 2010 [Summary] =>The Roche Group posted solid overall results in 2010. Group sales were stable in local currencies at 47.5 billion Swiss francs.
[DatePublished] => 2011-02-08 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Business [SectionUrl] => business [URL] => ) [1] => Array ( [ArticleID] => 595712 [Title] => Roche posts strong first half results [Summary] =>Roche CEO Severin Schwan announced yesterday that “Roche achieved a strong operating performance in the first half of 2010 despite an increasingly challenging market environment.
[DatePublished] => 2010-07-24 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Business [SectionUrl] => business [URL] => ) [2] => Array ( [ArticleID] => 551569 [Title] => Greater chances of cure for patients with breast cancer [Summary] =>Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
[DatePublished] => 2010-02-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) ) )
PHARMACEUTICALS DIVISION
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 654976 [Title] => Roche posts solid results in 2010 [Summary] =>The Roche Group posted solid overall results in 2010. Group sales were stable in local currencies at 47.5 billion Swiss francs.
[DatePublished] => 2011-02-08 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Business [SectionUrl] => business [URL] => ) [1] => Array ( [ArticleID] => 595712 [Title] => Roche posts strong first half results [Summary] =>Roche CEO Severin Schwan announced yesterday that “Roche achieved a strong operating performance in the first half of 2010 despite an increasingly challenging market environment.
[DatePublished] => 2010-07-24 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Business [SectionUrl] => business [URL] => ) [2] => Array ( [ArticleID] => 551569 [Title] => Greater chances of cure for patients with breast cancer [Summary] =>Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
[DatePublished] => 2010-02-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) ) )
abtest
EZ2 - 13 20
SUERTRES - 2 4 8
6D Lotto - 7 3 9 0 4 7
6/42 Lotto - 5 12 23 19 34 25
P16,891,422.00
6/49 Super Lotto - 46 33 45 23 31 1
P15,840,000.00
- 12:00 am